ArticleEndocrine2026
A post-operative fluid restriction protocol reduces the incidence of delayed hyponatremia following trans-sphenoidal pituitary surgery.
Article in Endocrine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThe study assessed the effect of a postoperative fluid restriction on the incidence of delayed hyponatremia (DH) following transsphenoidal pituitary surgery (TSS). The incidence of DH in the prospective cohort was compared to that of a published retrospective cohort from our centre managed according to the standard postoperative protocol without fluid restriction.
methodsThis prospective interventional study included patients aged ≥18 years who underwent TSS for pituitary neuroendocrine tumors (PitNETs). A structured postoperative fluid restriction of ≤1.5 L/day was implemented from post-operative day 5 (POD5) to POD14, with daily intake/output monitoring. Serum sodium was measured at defined postoperative intervals. DH incidence in the prospective cohort was compared with a previously published retrospective cohort managed without fluid restriction. Patient adherence and satisfaction were assessed using a study-specific questionnaire.
resultsThe study included 78 patients with a mean(SD) age of 42.6(11.9) years. Seventy-two (92.3%) patients had macroadenomas and 35.9% of the tumors were invasive. Twelve (15.4%) patients developed early transient AVP deficiency. Eleven (14.1%) patients developed DH between POD 5-14, compared to 36% in the retrospective cohort (p = 0.001). None in the prospective cohort required readmission or prolonged hospitalization for hyponatremia and the hyponatremia resolved with further tighter fluid restriction. Seven patients developed mild asymptomatic hypernatremia/increased serum osmolarity which resolved with relaxation of fluid intake.
conclusionA structured fluid restriction protocol of ≤1.5 L/day in the post-operative period may be safe and effective in reducing the incidence of delayed hyponatremia and readmissions following transsphenoidal pituitary surgery for PitNETs in a tropical setting.
Indexed as
Identifiers
42842140What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.